tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Rakovina and NanoPalm to Form Joint Venture for AI-Driven Oncology Therapies
Company AnnouncementsRakovina and NanoPalm to Form Joint Venture for AI-Driven Oncology Therapies
13d ago
Rakovina Therapeutics Strengthens Cancer Therapy Development Through Strategic Academic Partnership
PremiumCompany Announcements
Rakovina Therapeutics Strengthens Cancer Therapy Development Through Strategic Academic Partnership
26d ago
Rakovina Therapeutics Grants Stock Options to Propel AI-Powered Cancer Therapy Development
PremiumCompany Announcements
Rakovina Therapeutics Grants Stock Options to Propel AI-Powered Cancer Therapy Development
26d ago
Rakovina Therapeutics Launches Warrant Exercise Incentive Program
PremiumCompany Announcements
Rakovina Therapeutics Launches Warrant Exercise Incentive Program
1M ago
Rakovina Therapeutics Advances AI-Driven ATR Inhibitor Program
PremiumCompany Announcements
Rakovina Therapeutics Advances AI-Driven ATR Inhibitor Program
1M ago
Rakovina Therapeutics Expands U.S. Market Access with DTC Eligibility
PremiumCompany AnnouncementsRakovina Therapeutics Expands U.S. Market Access with DTC Eligibility
1M ago
Rakovina Therapeutics Applauds Variational AI’s Award for AI-Driven Drug Discovery
Premium
Company Announcements
Rakovina Therapeutics Applauds Variational AI’s Award for AI-Driven Drug Discovery
1M ago
Rakovina Therapeutics Strengthens AI-Driven Cancer Drug Development with Expert Advisory Board
Premium
Company Announcements
Rakovina Therapeutics Strengthens AI-Driven Cancer Drug Development with Expert Advisory Board
2M ago
Rakovina Therapeutics Plans Amendments to Debentures and Warrants
PremiumCompany Announcements
Rakovina Therapeutics Plans Amendments to Debentures and Warrants
2M ago
Rakovina Therapeutics Advances AI-Driven Cancer Therapies and Strategic Growth in 2025
PremiumCompany Announcements
Rakovina Therapeutics Advances AI-Driven Cancer Therapies and Strategic Growth in 2025
2M ago
Rakovina Therapeutics Reports 2025 AGM Outcomes and Strategic Advancements
PremiumCompany Announcements
Rakovina Therapeutics Reports 2025 AGM Outcomes and Strategic Advancements
2M ago
Rakovina Therapeutics Sets Date for Share Consolidation
PremiumCompany Announcements
Rakovina Therapeutics Sets Date for Share Consolidation
2M ago
Rakovina Therapeutics Seeks Strategic Partnerships at BIO Convention
PremiumCompany AnnouncementsRakovina Therapeutics Seeks Strategic Partnerships at BIO Convention
2M ago
Rakovina Therapeutics Secures $4.9 Million in Oversubscribed Private Placement
Premium
Company Announcements
Rakovina Therapeutics Secures $4.9 Million in Oversubscribed Private Placement
3M ago
Rakovina Therapeutics Reports Q1 2025 Financials and Strategic Developments
Premium
Company Announcements
Rakovina Therapeutics Reports Q1 2025 Financials and Strategic Developments
3M ago
Rakovina Therapeutics Debentureholders Opt for Shares in Interest Payment
PremiumCompany Announcements
Rakovina Therapeutics Debentureholders Opt for Shares in Interest Payment
3M ago
Rakovina Therapeutics Secures $4 Million for U.S. Growth and AI Oncology Innovation
PremiumCompany Announcements
Rakovina Therapeutics Secures $4 Million for U.S. Growth and AI Oncology Innovation
3M ago
Rakovina Therapeutics Appoints Dr. David Kideckel as CFO Amid Growth Phase
PremiumCompany Announcements
Rakovina Therapeutics Appoints Dr. David Kideckel as CFO Amid Growth Phase
4M ago
Rakovina Therapeutics Reports 2024 Financial Results and Strategic Advances in AI-Driven Cancer Therapies
PremiumCompany Announcements
Rakovina Therapeutics Reports 2024 Financial Results and Strategic Advances in AI-Driven Cancer Therapies
4M ago
Rakovina Therapeutics Strengthens Board with Strategic Appointments
PremiumCompany AnnouncementsRakovina Therapeutics Strengthens Board with Strategic Appointments
4M ago
Rakovina Therapeutics Unveils AI-Driven Cancer Therapy Advances at AACR 2025
Premium
Company Announcements
Rakovina Therapeutics Unveils AI-Driven Cancer Therapy Advances at AACR 2025
4M ago
Rakovina Therapeutics Celebrates AI Breakthrough in Cancer Drug Discovery
Premium
Company Announcements
Rakovina Therapeutics Celebrates AI Breakthrough in Cancer Drug Discovery
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >